Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Is persistence to bisphosphona...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Is persistence to bisphosphonate therapy related only to dosing regimen?
Bibliographic Details
Main Authors:
van Staa, T
,
Leufkens, H
,
Cooper, C
Format:
Conference item
Published:
2006
Holdings
Description
Similar Items
Staff View
Similar Items
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
by: van Staa, T, et al.
Published: (2007)
The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
by: van Staa, T, et al.
Published: (2007)
Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis
by: Ülkü Akarırmak, et al.
Published: (2016-08-01)
Fracture risk with intermittent high-dose oral glucocorticoid therapy.
by: De Vries, F, et al.
Published: (2007)
Fracture risk in patients receiving concomitant bisphosphonate and proton pump inhibitors or bisphosphonates alone: The UK general practice research database
by: de Vries, F, et al.
Published: (2008)